Jump ahead to 2015, CVS Health acquired Target's pharmacy and retail clinic businesses.
The company released earnings Wednesday, Feb. 20.
Real Money's Stock of the Day, CVS Health, said adjusted earnings for the three months ending in December came in at $2.14 per share, up 11.5% from the same period last year and firmly ahead of the Street consensus of $2.05 per share. Group revenues, CVS said, rose 12.5% to $54.424 billion, a figure that fell modestly shy of the consensus estimate of $54.58 billion. CVS also said it took a $2.2 billion goodwill impairment charge linked to its long-term care (LTC) business.
Looking into 2019, CVS said it sees cash flow from operations in the range of $9.8 billion to $10.3 billion and full-year GAAP earnings of between $4.88 and $5.08 per share, or $6.68 to $6.88 on an adjusted basis, well below the Refinitiv forecast of $7.41 per share and the 2018 tally of $7.08 per share.